The in vitro activity of a new quinolone, T-3262 [A-60969; DL-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-l-,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid monohydrate], was compared with those of ciprofloxacin, ofloxacin, ceftazidime, imipenem, and gentamicin. T-3262 inhibited 90% of isolates of the family Enterobacteriaceae at a concentration of s0.25 ,ug/ml. It was two to four times more active than ofloxacin and similarly or slightly less active than ciprofloxacin. Ninety percent of isolates of Pseudomonas aeruginosa were inhibited at 0.5 ,Lg/ml. It was 4-to 8-fold more active than ciprofloxacin and 8-to 16- There has been continued interest in the synthesis of new quinolones. Although many of the new agents of the quinolone class have excellent in vitro activity against members of the family Enterobacteriaceae and Pseudomonas aeruginosa, activity against some gram-positive species and against many anaerobic species is variable (3, 6, 8) . Compound T-3262, also referred to as A-60969, is a new trifluoronaphthyridine quinolone. The chemical structure is DL-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1-,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid monohydrate.
considerably more active than ciprofloxacin and ofloxacin. The frequency of spontaneous point mutational resistance was <10-10 for members of the family Enterobacteriaceae and Pseudomonas spp. Resistant strains could be selected by repeated subculture. Similar to other quinolones, its activity could be affected by culture conditions. T-3262 showed a postantibiotic suppressive effect on Escherichia coli, P. aeruginosa, and S. aureus.
There has been continued interest in the synthesis of new quinolones. Although many of the new agents of the quinolone class have excellent in vitro activity against members of the family Enterobacteriaceae and Pseudomonas aeruginosa, activity against some gram-positive species and against many anaerobic species is variable (3, 6, 8) . Compound T-3262, also referred to as A-60969, is a new trifluoronaphthyridine quinolone. The chemical structure is DL-7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1-,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid monohydrate.
We have compared the activity of this new agent with those of other quinolones, ceftazidime, imipenem, and gentamicin and have determined the effect of various assay conditions on its activity.
MATERIALS AND METHODS
The compound designated T-3262 was a gift from Toyama Chemical Co., Ltd., Tokyo, Japan, and that designated A-60969 was provided by Abbott Laboratories, Abbott Park, Ill. All other agents were obtained from their respective manufacturers. Quinolones were prepared as published previously (1, 6) . Fresh dilutions of all compounds used were prepared daily. Bacterial isolates were obtained from patients hospitalized at The Presbyterian Hospital in New York City. Only one isolate from each patient was tested to avoid multiple copies of the same strain.
Antimicrobial susceptibility tests. Antimicrobial susceptibility was measured by an agar dilution method with Mueller-Hinton agar. A replicating spot device applied 104 CFU, prepared by dilution of a fresh overnight broth. Broth dilutions were performed with 5 x 105 CFU in tubes of 1-ml volume. The MIC was defined as the lowest concentration of antimicrobial agent that inhibited the development of visible growth on agar or in the tubes. The MBC was determined by plating 0.01 ml from clear tubes to agar plates. The MBC was the concentration at which there was a 99.9% reduction in CFU by the method of Pearson et al. (8) . The effect of serum, urine, pH, and ion changes in the medium were determined as described previously (1, 6 moved. Thereafter, the number of CFU was determined every hour for the first 4 h and every 2 h up to 10 h. The PAE was measured as described by Craig and Gudmundsson (4) as the difference in time required by test and control cultures to increase 1 log after the antibiotic was removed.
RESULTS
Compound T-3262 inhibited 50% of isolates of the family Enterobacteriaceae and P. aeruginosa at c0.25 ug/Iml, and the MIC for 90% of the isolates was O0.5 ,ug/ml (Table 1) .
T-3262 was generally one to two dilutions less active than ciprofloxacin, with occasional exceptions. It was two-to eightfold more active than ofloxacin. T-3262 inhibited isolates of the family Enterobacteriaceae resistant to ceftazidime and gentamicin. It also inhibited, at <0.5 pug/ml, organisms with imipenem MICs of 8 ,ug/ml, and it inhibited, at s4 ,ug/ml, P. aeruginosa isolates resistant to ceftazidime and gentamicin.
T-3262 was more active than ciprofloxacin against Pseudomonas cepacia and Pseudomonas maltophilia and against Acinetobacter spp. It had activity equal to that of ciproflo- xacin against Haemophilus influenzae including 10 betain Table 3 . T-3262 was less active at pH 5.5 than at pH 7.5 for lactamase-producing isolates, and it inhibited 90% of Neisall of the species. There was a proportional increase in both seria gonorrhoeae strains at <0.25 ,ug/ml. Activity against MIC and MBC. The increase in MICs was also noted for beta-lactamase-producing strains of Haemophilus and Neisurine which had an acidic pH. In contrast, there was no seria spp. was similar to activity against nonproducing major increase in MBCs when the organisms were tested in isolates. Activity against Branhamella catarrhalis was sim-50% normal human serum. The geometric mean MIC for six ilar to that of ciprofloxacin, as was its activity against the strains of Klebsiella pneumoniae, Citrobacterfreundii, and small numbers of Legionella and Campylobacter species
Enterobacter cloacae was identical at pH 7.5 and 6.5, but tested.
increased for the K. pneumoniae strains from 0.1 to 1.3 Against the gram-positive species, T-3262 was consider-,ug/ml at pH 5.5. There was a marked increase in the MIC for ably more active than ciprofloxacin and ofloxacin (Table 2) .
Serratia marcescens strains, from 0.6 ,ug/ml at pH 7.5 to 22.6 It inhibited 90% of Staphylococcus aureus isolates at 0.125 p,g/ml at pH 5.5, and for P. aeruginosa strains, from 0.4 ,ug/ml compared with 1 ,ug/ml required for ciprofloxacin.
jig/ml at pH 7.5 to 4 ,ug/ml at pH 5.5. T-3262 was less active against coagulase-negative staphylo-
The activity of T-3262 was determined for eight isolates cocci, with a MIC for 90% of isolates of 0.5 ,ugIml. It each of Escherichia coli, Staphylococcus aureus, and Serinhibited 90% of Streptococcus pyogenes at <0.125 pLg/ml ratia marcescens under anaerobic conditions, and there was and other hemolytic streptococci, groups B, C, G, and F, at no difference or within twofold of the MICs determined .0.25 ,ugIml. It was fourfold more active than ciprofloxacin under aerobic conditions. MBCs were not determined.
and ofloxacin against enterococci and eightfold more active Mg2+ concentration has been shown to have an important against Streptococcus pneumoniae. The majority of viridans effect on the MICs of most quinolones. Table 4 shows the group streptococci were inhibited by .0.5 ,ug/ml, as were effect of increasing concentrations of Mg2+. There was a Listeria spp. and Corynebacterium sp. strain JK.
minor increase in MICs at 9 mM Mg2+ for the organisms T-3262 inhibited 90% of Bacteroides fragilis at .2 ,ug/ml, tested, with the exception of Staphylococcus aureus. and it inhibited a small number of other Bacteroides spp.
The activity of T-3262 against E. coli JF568, which lacked tested, namely, two B. melaninogenicus, two B. ovatus, outer membrane protein F, was compared with that against three B. thetaiotaomicron, and three B. bivius isolates, at <1 the parent strain. There was a twofold difference in MIC for ,ugIml. The MICs of ofloxacin and ciprofloxacin for these the parent and the OMP C-strain, 0.03 ,ug/ml each, versus isolates had previously been shown to be .8 ,ug/ml (data not that for the OMP F-strain, 0.06 ,ug/ml. shown). It also showed excellent activity against Clostridium Development of resistance to T-3262. Table 5 shows the species and peptococci and peptostreptococci. development of resistance to T-3262 for eight different Effect of various conditions on activity. The effects of species. The increase for E. coli was only from 0.03 to 0.12 alterations of pH, incubation of serum, and urine are shown ,ug/ml, but for C. freundii and Serratia marcescens the When T-3262 was tested against isolates that had been encountered clinically during therapy of infections with ofloxacin or ciprofloxacin in which the MICs had increased to both of these agents, there was an increase in the T-3262 MICs. For example, for a K. pneumoniae strain with an original T-3262 MIC of 0.03 ,ug/ml, the T-3262 MIC increased to 0.5 p,g/ml for an isolate that had increased its MIC of ofloxacin from 0.25 to 2 ,g/ml. In a Serratia marcescens isolate with initial ciprofloxacin and T-3262 MICs of 0.12 V,g/ml, an increase to 4 ,ug of each agent per ml occurred, and a P. aeruginosa isolate from a cystic fibrosis patient had a MIC increase from 1 to 16 ,ug of each agent per ml.
The frequency of spontaneous resistance to T-3262 to concentrations four and eight times the MICs was 10-9 to <10-10 (Table 6) .
Killing curves and PAE. Exposure of a P. aeruginosa strain with a T-3262 MIC of 0.25 ,ug/ml to concentrations of two, four, and eight times the MIC produced 3-, 3.5-, and 6-log decreases in CFU in 2 h. No regrowth of bacteria occurred during the next 8 h, but regrowth at 24 h was seen for the sample which contained T-3262 at twice the MIC, whereas none was noted for the other two concentrations.
T (Table 7) .
DISCUSSION
In this study T-3262, a new quinolone, in contrast to many of the other quinolones, had excellent activity against grampositive species, particularly streptococci. It inhibited isolates of the family Enterobacteriaceae and P. aeruginosa at concentrations similar or superior to available quinolones (3, 7, 9 ). This agent was slightly less active than ciprofloxacin against enteric species and P. aeruginosa, but, like ciprofloxacin, it inhibited aminoglycoside-, cephalosporin-, and even imipenem-resistant isolates. T-3262 inhibited the anaerobic species tested at c2 ,ug/ml, which is in contrast to other quinolones (7, 9) . Like other quinolones, this agent had a reduction of activity at acid, pH 5.5, conditions but not at pH 6.5 (1, 6) . Its activity was minimally decreased by high Mg2+ concentrations, but there was a significant increase in MICs in pH 5.5 urine. In contrast, we had earlier shown that there was an eightfold increase in MICs when the Mg2+ concentration increased from 0.3 to 9 mM (6) . At the concentrations anticipated in urine, it showed a marked, rapid killing and a prolonged PAE even with pathogens selected for higher MICs. This is similar to what we have shown for ciprofloxacin (2).
T-3262 had a low frequency of spontaneous resistance, but as with other quinolones resistant isolates could be selected by repeated passage in the drug, and clinical isolates with higher ofloxacin and ciprofloxacin MICs that appeared during therapy of infections had higher T-3262 MICs. Similar to what has been shown for quinolones by Hirai et al. (5), an E. coli isolate lacking outer membrane protein F is less suscep- 
